Jade Biosciences, Inc. Accumulated Other Comprehensive Income
Jade Biosciences, Inc. (JBIO) had Accumulated Other Comprehensive Income of -$660.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-10
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$660.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$342.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $129.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $29.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$660.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$342.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $129.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $29.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$24.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $50.00K 10-Q · filed 2025-04-25 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-06 | $105.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $224.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$83.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$33.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $237.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$195.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$223.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$201.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$466.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | -$771.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$785.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$644.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$59.00K 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |